The top documents tagged [evaluable patients]

Access Pharmaceuticals, Inc. Investor Presentation
Health & Medicine Access Pharmaceuticals, Inc. Investor Presentation

1.449 views

EHA highlights News in MDS JULY31, TYR,LEBANON MARCEL MASSOUD, M.D
Documents EHA highlights News in MDS JULY31, TYR,LEBANON MARCEL MASSOUD, M.D

216 views

Endocrinology of Prostate Cancer. Hormonal Pathways of the Male Endocrine System
Documents Endocrinology of Prostate Cancer. Hormonal Pathways of the Male Endocrine System

223 views

By Dr. Michael A. Prytula ND and staff. Include Ozone, UVB, Hydrogen Peroxide, Hyperbaric Oxygen and by mechanism of action…. Ascorbic Acid in high
Documents By Dr. Michael A. Prytula ND and staff. Include Ozone, UVB, Hydrogen Peroxide, Hyperbaric Oxygen and by mechanism of action…. Ascorbic Acid in high

220 views

Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: a randomized
Documents Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: a randomized

215 views

The Genetics of Cancer: Is Personalization of Cancer Treatment Possible? Keith T. Flaherty, M.D. Massachusetts General Hospital Cancer Center
Documents The Genetics of Cancer: Is Personalization of Cancer Treatment Possible? Keith T. Flaherty, M.D. Massachusetts General Hospital Cancer Center

220 views

CLL Stromal cell protect Conventional therapies Versteckspiel im Wald by Friedrich Eduard Meyerheim (1808-1879) The “outside” (microenvironment) of the
Documents CLL Stromal cell protect Conventional therapies Versteckspiel im Wald by Friedrich Eduard Meyerheim (1808-1879) The “outside” (microenvironment) of the

214 views

Updated Safety Data from a Randomized Phase 2 Trial of Hedgehog Pathway Inhibitor GDC-0449 vs. Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients
Documents Updated Safety Data from a Randomized Phase 2 Trial of Hedgehog Pathway Inhibitor GDC-0449 vs. Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients

217 views

1 New Developments in the Management of Advanced Breast Cancer Supported by an educational grant from Roche Laboratories Including Updates from ASCO 2007
Documents 1 New Developments in the Management of Advanced Breast Cancer Supported by an educational grant from Roche Laboratories Including Updates from ASCO 2007

216 views

DEEP Project presentation 03/03/2014 – Caltanissetta Donato Bonifazi – DEEP2 Trial Leader Aurelio Maggio – Trial Coordinating Investigator Lorella Pitrolo
Documents DEEP Project presentation 03/03/2014 – Caltanissetta Donato Bonifazi – DEEP2 Trial Leader Aurelio Maggio – Trial Coordinating Investigator Lorella Pitrolo

222 views

Complete remissions with SGN-35 weekly dosing: a phase 1 dose-escalation study in relapsed/refractory HL or systemic ALCL patients Nancy L Bartlett, Andres
Documents Complete remissions with SGN-35 weekly dosing: a phase 1 dose-escalation study in relapsed/refractory HL or systemic ALCL patients Nancy L Bartlett, Andres

214 views

neuro-infection journal
Documents neuro-infection journal

26 views